These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 4650116)

  • 1. Rate of appearance of metabolites in the rat pancreatic juice after administration of 14 C-L-DOPA. A preliminary report.
    Alm P; Ekholm R; Ericson L
    Acta Pharm Suec; 1972 Nov; 9(5):401-4. PubMed ID: 4650116
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebral accumulation and metabolism of C14-dopa after selective inhibition of peripheral decarboxylase.
    Bartholini G; Pletscher A
    J Pharmacol Exp Ther; 1968 May; 161(1):14-20. PubMed ID: 5648492
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of L-aromatic amino acid decarboxylase inhibition on metabolism of dihydroxyphenylalanine by isolated perfused rat liver.
    Tyce GM; Owen CA
    Biochem Pharmacol; 1972 Nov; 21(22):2977-89. PubMed ID: 4649349
    [No Abstract]   [Full Text] [Related]  

  • 4. The fate of C14-dihydroxyphenylalanine (C14-dopa) in the whole mouse.
    Wurtman RJ; Chou C; Rose C
    J Pharmacol Exp Ther; 1970 Sep; 174(3):351-6. PubMed ID: 5456168
    [No Abstract]   [Full Text] [Related]  

  • 5. Fate of radioactive exocrine pancreatic proteins injected into the blood circulation of the rat. Tissue uptake and transepithelial excretion.
    Rohr G; Scheele G
    Gastroenterology; 1983 Nov; 85(5):991-1002. PubMed ID: 6618114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the metabolism of D- and L-isomers of 3,4-dihydroxyphenylalanine (DOPA). IV. Urinary and tissue metabolites of D- and L-DOPA-14C after intravenous and oral administration to rats.
    Shindo H; Komai T; Tanaka K; Nakajima E; Miyakoshi N
    Chem Pharm Bull (Tokyo); 1973 Apr; 21(4):826-36. PubMed ID: 4727355
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of pancreatic exocrine secretion using 13C-dipeptide (benzoyl-L-tyrosyl-[1-(13)C]alanine) breath test: focusing on pancreatoduodenectomy cases.
    Ishii Y; Kohno T; Ito A; Suzuki S; Kohno T; Takayama T; Asai S
    Pancreas; 2007 Nov; 35(4):313-9. PubMed ID: 18090236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of metabolites of L-dopa--a possible source of error.
    Tyce GM; Sharpless NS; Owen CA
    Biochem Pharmacol; 1972 Sep; 21(17):2409-12. PubMed ID: 4647075
    [No Abstract]   [Full Text] [Related]  

  • 9. The metabolic pathways of L-3-O-methyldopa.
    Bartholini G; Kuruma I; Pletscher A
    J Pharmacol Exp Ther; 1972 Oct; 183(1):65-72. PubMed ID: 5080035
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics of 5-fluorouracil and its penetration into pancreatic juice in dogs.
    Zhu Z; Fu Q; Nightingale CH; Zhao YP; Liao Q; Wang HN; Xue CQ; Yang ZY; Li DK
    Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):7-9. PubMed ID: 10375748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic 13C-dipeptide breath test for the rapid assessment of pancreatic exocrine insufficiency in rats.
    Kohno T; Ito A; Hosoi I; Hirayama J; Shibata K
    Scand J Gastroenterol; 2007 Aug; 42(8):992-9. PubMed ID: 17613930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral aromatic L-amino acids decarboxylase inhibitor in Parkinsonism. I. Effect on O-methylated metabolites of L-dopa-2- 14 C.
    Messiha FS; Hsu TH; Bianchine JR
    J Clin Invest; 1972 Feb; 51(2):452-5. PubMed ID: 5009125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of L-dopa administration of the concentrations of dopa, dopamine and norepinephrine in various rat tissues.
    Romero JA; Lytle LD; Ordonez LA; Wurtman RJ
    J Pharmacol Exp Ther; 1973 Jan; 184(1):67-72. PubMed ID: 4686016
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the metabolism of D- and L-isomers of 3,4-dihydroxyphenylalanine (DOPA). II. Autoradiographic study on the distribution of 14 C-labeled D- and L-DOPA after oral administration in rats.
    Shindo H; Miyakoshi N; Nakajima E
    Chem Pharm Bull (Tokyo); 1972 May; 20(5):966-73. PubMed ID: 5055126
    [No Abstract]   [Full Text] [Related]  

  • 15. Formation of p-tyramine from DOPA and DOPamine in rat brain.
    Boulton AA; Quan L
    Can J Biochem; 1970 Dec; 48(12):1287-91. PubMed ID: 5510941
    [No Abstract]   [Full Text] [Related]  

  • 16. Regional effects of L-dihydroxyphenylalanine (L-dopa) on norepinephrine metabolism in rat brain.
    Romero JA; Chalmers JP; Cottman K; Lytle LD; Wurtman RJ
    J Pharmacol Exp Ther; 1972 Feb; 180(2):277-85. PubMed ID: 5010674
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates.
    Ng LK; Colburn RW; Kopin IJ
    J Pharmacol Exp Ther; 1972 Nov; 183(2):316-25. PubMed ID: 5083548
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of L-DOPA on S-adenosylmethionine levels and norepinephrine metabolism in rat brain.
    Wurtman RJ
    Adv Biochem Psychopharmacol; 1972; 6():241-6. PubMed ID: 5055596
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the metabolism of D- and L-isomers of 3,4-dihydroxyphenylalanine (DOPA). 3. Absorption, distribution and excretion of D- and L-DOPA-14C in rats following intravenous and oral administration.
    Shindo H; Nakajima E; Kawai K; Miyakoshi N; Tanaka K
    Chem Pharm Bull (Tokyo); 1973 Apr; 21(4):817-25. PubMed ID: 4727354
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholesterol esterase activity of rat pancreatic juice. Effect of pH and bile salt on the enzyme-catalysed equilibrium state.
    Filipek-Wender H; Borgström B
    Acta Biochim Pol; 1971; 18(1):1-10. PubMed ID: 5092131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.